Karuna Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRTX and other ETFs, options, and stocks.

About KRTX

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. 

CEO
Steven Marc Paul
CEOSteven Marc Paul
Employees
118
Employees118
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2009
Founded2009
Employees
118
Employees118

KRTX Key Statistics

Market cap
7.95B
Market cap7.95B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
274.00K
Average volume274.00K
High today
$232.37
High today$232.37
Low today
$226.92
Low today$226.92
Open price
$229.12
Open price$229.12
Volume
44.42K
Volume44.42K
52 Week high
$278.25
52 Week high$278.25
52 Week low
$92.26
52 Week low$92.26

Analyst ratings

100%

of 18 ratings
Buy
100%
Hold
0%
Sell
0%

KRTX Earnings

-$2.38
-$1.59
-$0.79
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.